| Patient | William Shakespeare |
|---|---|
| Date of birth | 1974-05-03 |
| Identifiers | MRN HR-RE005-SYN; SSN (made up) 000-05-9036 |
| Document date | 2026-03-23 |
| Author | Rowena Achterberg-Sule, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review after four weeks on propranolol 80 mg, with liver tests. [S]
Mr. Shakespeare returns four weeks after the propranolol dose was increased to 80 mg each morning. He has had two occupational therapy sessions: he now writes with a weighted, wide-grip pen, rests his forearm on the desk, writes a little larger and slower, and dictates long drafts. He can sign his name steadily if he signs halfway down a page rather than at the very foot. He has had no dizziness, wheeze, cold hands, fatigue, or low mood. He has kept within the agreed limits since the brief intervention ten weeks ago, at about 10 drinks a week with no day above three for the last five, and two cups of coffee. He feels his hand is his own again. [S]
| Element | Detail |
|---|---|
| Medication | Propranolol extended-release 80 mg for four weeks; no side effects |
| Occupational therapy | Two sessions; weighted wide-grip pen, forearm support, dictation |
| Writing | Full pages legible; signature steady |
| Alcohol | Within limits for ten weeks; about 10 drinks a week for the last five |
| System | Result | Finding |
|---|---|---|
| Neurological | Positive | Mild residual tremor when tired; no new symptoms |
| Cardiovascular | Negative | No dizziness or fainting |
| Respiratory | Negative | No wheeze |
| Psychiatric | Negative | Mood good |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Propranolol extended-release 60 mg oral capsule, one capsule by mouth each morning | One capsule each morning | Oral route | 2026-01-26 to 2026-02-23 | completed | S |
| Propranolol extended-release 80 mg oral capsule, one capsule by mouth each morning | One capsule each morning | Oral route | 2026-02-23 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-23 | Body height | 175 | cm | S |
| 2026-03-23 | Body weight | 80.8 | kg | S |
| 2026-03-23 | Body mass index (BMI) [Ratio] | 26.4 | kg/m2 | S |
| 2026-03-23 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-03-23 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-03-23 | Heart rate | 62 | /min | S |
| 2026-03-23 | Respiratory rate | 14 | /min | S |
| 2026-03-23 | Body temperature | 36.6 | Cel | S |
| 2026-03-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-23 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 49 | U/L | 8-61 U/L | Normal | S |
| 2026-03-23 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-55 U/L | Normal | S |
| 2026-03-23 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 29 | U/L | 8-48 U/L | Normal | S |
Vital signs recorded on 2026-03-23; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Cardiovascular | Heart rate 62, regular; blood pressure 120/76 mmHg seated and 118/76 mmHg standing |
| Respiratory | Clear |
| Abdomen | Liver not enlarged |
| Neurological | Mild postural and kinetic tremor of both hands, right more than left; no rest tremor or other signs |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tremor of the writing hand for six months, with shaky, effortful handwriting and spilling from cups; under evaluation | resolved | confirmed | R25.1 | S — Synthetic presenting problem echoing, without asserting, the shaky signatures on his 1616 will (CLM-0006, R); superseded by the diagnosis at the second visit. |
| Essential tremor (MDS 2018 criteria): bilateral upper-limb postural and kinetic tremor, right more than left, for at least three years, worse over six months, without head or voice tremor or other neurological signs; enhanced by alcohol rebound and caffeine; thyroid and metabolic causes excluded | active | confirmed | G25.0 | S — Synthetic modern diagnosis. The shakiness of his signatures is documented as an interpretation (CLM-0006, R, possible); no tremor is documented in his lifetime, and the mercury hypothesis (CLM-0010) is disputed. |
| Hazardous drinking (AUDIT 12; about 24 standard drinks a week with heavier evenings with friends), without an alcohol use disorder; raised GGT | active | confirmed | Z72.89 | S — Synthetic finding. The only historical mention of his drinking is a story written down decades after his death (CLM-0008, R); it is not treated as evidence of his habits. |
| Acute viral upper respiratory infection (common cold) with a low-grade fever, one week after starting propranolol; resolved | resolved | confirmed | J06.9 | S — Synthetic intercurrent illness; it does not assert anything about the fever in John Ward's later story (CLM-0008, R). |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Tremor rating: TETRAS performance and activities of daily living subscales | At each visit while treatment is adjusted | Completed today | Performance 12 (from 22) and activities of daily living 9 (from 18); writing item 1.5 |
| Examination | Archimedes spiral and handwriting sample (the same sentence each time, dated and kept in the chart) | At each visit while treatment is adjusted | Completed today | Right spiral close to the left, with a small tremor axis; handwriting even and legible across a full page |
| Medication safety | Beta-blocker safety: resting pulse, seated and standing blood pressure, wheeze, fatigue, cold hands, low mood, exercise tolerance | At each visit after starting or changing the dose | Completed today | Pulse 62; blood pressure 120/76 mmHg with no postural drop; no wheeze, fatigue, cold hands, or low mood |
| Self-management | Drinking review after the brief intervention (drinks a week, heaviest day, use of alcohol to steady the hand) | At each visit after a brief intervention | Completed today | About 10 drinks a week for the last five weeks, no day above three; within limits for ten weeks |
| Laboratory | GGT and liver tests after reducing alcohol | Eight to twelve weeks after the brief intervention | Completed today | GGT 49 U/L (from 84), ALT 30 U/L, AST 29 U/L |
| Referral | Occupational therapy for writing | When tremor limits writing | Completed today | Two sessions completed; techniques in use |
| Self-management | Advance care planning and goals of care | Once, then when health or wishes change | Up to date | Discussed at the preventive visit; health care agent named |
| Medication safety | Primidone (sedation, unsteadiness, nausea) | Only if used | Not indicated | Not started; propranolol is effective and tolerated |
| Imaging | Brain MRI or dopamine transporter imaging | Only for atypical features (rest tremor, parkinsonism, asymmetry with other signs, sudden onset, ataxia) | Not indicated | No atypical features; the diagnosis is clinical |
| Referral | Deep brain stimulation or focused ultrasound thalamotomy | Only for disabling tremor despite adequate trials of two first-line drugs | Not indicated | Tremor responding to the first drug |
Goal progress:
Guideline basis: Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology (2011; reaffirmed 2025) (2011); Consensus Statement on the classification of tremors, from the task force on tremor of the International Parkinson and Movement Disorder Society (2018); MDS evidence-based review of treatments for essential tremor (2019); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018); Helping Patients Who Drink Too Much: A Clinician's Guide (2005); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026)
Follow-up: Tremor review in three months; second zoster dose due in the next two months; he has not yet returned the fecal immunochemical test kit and was reminded today. [S]